Physician profile
William Mook
NPI 1528201134
$5,132.90
in general payments reported to CMS, 2019-2025
14 companies · $338 in 2025
The $338 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,288 · 2020: $242 · 2021: $37.53 · 2022: $1,824 · 2023: $1,086 · 2024: $318 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $974 · Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $974.20 |
| Food and Beverage | $767.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,078.76 | 2019-2025 | Blueprint Patient Specific Instrumentation, Pangea |
| Supreme Orthopedic Systems, LLC | $686.52 | 2022-2023 | |
| Smith+Nephew, INC. | $606.44 | 2019-2024 | Bone Anchors With Arthroscopic Delivery System, Acufex |
| Arthrex, INC. | $442.48 | 2023 | |
| Vericel Corporation | $66.97 | 2021-2023 | Maci |
| Depuy Synthes Sales INC. | $55.61 | 2019-2024 | Inhance |
| Abbott Laboratories | $36.87 | 2019 | |
| Innovation Technologies INC | $34.44 | 2022 | |
| Bioventus LLC | $32.01 | 2024 | Durolane |
| Pacira Pharmaceuticals Incorporated | $28.23 | 2019 | |
| Endo Pharmaceuticals INC. | $22.04 | 2019 | |
| Ethicon US, LLC | $17.99 | 2019 | |
| Dynasplint Systems INC. | $12.47 | 2019 | |
| Integra Lifesciences Corporation | $12.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.